我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Merck & Co.: Evaluating a Drug Licensing Opportunity

商品編號: 9-201-023
出版日期: 2000/10/30
作者姓名:
Ruback, Richard S.;Krieger, David
商品類別: Finance
商品規格: 6p

再版日期: 2003/03/25
地域:
產業:
個案年度: 1999 -  1999

 


商品敘述:

This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck''s decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of the three phases of the review process, the revenues if approved, and the probability of various outcomes. It includes an introduction to decision tree analysis and valuation.


涵蓋領域:

Corporate finance;Decision making;Intellectual property


相關資料:

Spreadsheet Supplement, (9-201-707), 0p, by Richard S. Ruback, David Krieger;
Case Teaching Note, (5-202-001), 10p, by Richard S. Ruback, Aldo Sesia